By using immunoelectron microscopy we demonstrated that, in a mouse tumor model for human prostate cancer, FSHR is present on the luminal surface of the tumor ECs and can specifically bind and internalize anti-FSHR antibodies coupled to colloidal gold particles delivered in the circulation [94] (Figure 3). Here, FSHR is linked to prostate carcinoma.